* Tenet Healthcare Corp THC.N THC is expected to show a
rise
in quarterly revenue when it reports results on April 30 for
the period ending March 31 2024
* The Dallas Texas-based company is expected to report a
2.6% increase in revenue to $5.152 billion from $5.02 billion a
year ago, according to the mean estimate from 15 analysts, based
on LSEG data.The company's guidance on February 8 2024, for the
period ended March 31, was for revenue between $5.00 billion and
$5.20 billion.
* LSEG's mean analyst estimate for Tenet Healthcare Corp is
for
earnings of $1.43 per share. The company's EPS guidance on
February 8 2024, for the period ended March 31, was between
$1.24 and $1.62
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 17 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 3.7%
in the last three months.
* Wall Street's median 12-month price target for Tenet
Healthcare
Corp is $113.00, above its last closing price of $97.51.
The company's guidance on February 8 2024 for the period ended
March 31 was for Earnings before Interest, Taxes, Depreciation
and Amortization of between USD5 billion and USD850 million.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 1.67 1.60 2.68 Beat 67.3
Sep. 30 2023 1.23 1.20 1.44 Beat 20.4
Jun. 30 2023 1.29 1.25 1.44 Beat 15.3
Mar. 31 2023 1.16 1.16 1.42 Beat 22.9
Dec. 1.26 1.23 1.96 Beat 59.7
31 2022
Sep. 30 2022 1.26 1.22 1.44 Beat 18.1
Jun. 30 2022 0.73 0.79 1.50 Beat 89.2
Mar. 31 2022 1.07 1.04 1.93 Beat 85.5
This summary was machine generated April 26 at 14:13 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)